SPL 2.20% 8.9¢ starpharma holdings limited

Viraleze and BTB grant

  1. 321 Posts.
    lightbulb Created with Sketch. 84
    BTB grant report :
    Australianbiotech takesbroad-spectrumantiviral nasal sprayto the worldPROJECT:Viraleze™ Antiviral Nasal Spray - StarpharmaTHERAPEUTIC AREA:COVID-19, Infectious Diseasestarpharma
    START DATE:7 September2020
    END DATE:31 August 2021
    STATUS:Completed
    DELIVERABLESCOMPLETED:100%
    TOTAL BTB GRANT:$1,000,000
    TOp-up FUNDING:$103,750
    TOTAL BTB EXPENDITURE:$1,103,750
    TOTAL CASH CO-CONTRIBUTION:$1,737,398
    TOTAL IN-KIND:$416,772
    TOTAL PROGRAM:$3,257,920
    Jobs within project budget (FTEs dedicated to project) 3
    New jobs created as a result of this project. 3
    Number of new technologies invented. 1


    Thanks you to stupid govt for giving SPL $1.1m to pay Management excessive salary when SPL has $50m of cash in bank and product not make meaningful revenue. IMO I add:
    Profit:$0
    Unsucessful partnerships:Middle East, uk and Italy (Lloyds) and Vietnam
    profitable partnerships: 0
    deals promised but not done: india
    sponsorship: harlequin rugby team
    overpaid Execs:4
    Last edited by Biostock: 01/11/22
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
8.9¢
Change
-0.002(2.20%)
Mkt cap ! $36.67M
Open High Low Value Volume
9.3¢ 9.3¢ 8.9¢ $29.39K 323.4K

Buyers (Bids)

No. Vol. Price($)
2 242435 8.9¢
 

Sellers (Offers)

Price($) Vol. No.
9.1¢ 20000 1
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.